The effect of warfarin treatment on renal plasminogen activator inhibitor-1 and tissue factor gene expression in a rat model of type 2 diabetic nephropathy.

被引：0
|
作者：
Hagiwara, H
Li, W
Watanabe, K
Seki, T
Uriu, K
Takagi, I
Ling, QY
Ariga, T
Okada, K
Kaizu, K
机构：
[1] Nihon Univ, Grad Sch Appl Life Sci, Dept Nutr & Physiol, Fujisawa, Kanagawa, Japan
[2] Univ Occupat & Environm Hlth, Kidney Ctr, Kitakyushu, Fukuoka 807, Japan
[3] Nihon Univ, Sch Med, Dept Internal Med 2, Tokyo 173, Japan
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2003年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：391A / 391A
页数：1
相关论文
共 50 条
  • [21] Effect of carbohydrate side chain of tissue-type plasminogen activator on its interaction with plasminogen activator inhibitor-1
    Madoiwa, S
    Arai, K
    Mimuro, J
    Mori, K
    Asakura, S
    Matsuda, M
    Sakata, Y
    FIBRINOLYSIS & PROTEOLYSIS, 1998, 12 (01): : 17 - 22
  • [22] Tissue factor, plasminogen activator inhibitor-1, and thrombin receptor expression in human crescentic glomerulonephritis
    Grandaliano, G
    Gesualdo, L
    Ranieri, E
    Monno, R
    Schena, FP
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) : 726 - 738
  • [23] Local insulin infusion stimulates expression of plasminogen activator inhibitor-1 and tissue-type plasminogen activator in normal subjects
    Carmassi, F
    Morale, M
    Ferrini, L
    Dell'Omo, G
    Ferdeghini, M
    Pedrinelli, R
    De Negri, F
    AMERICAN JOURNAL OF MEDICINE, 1999, 107 (04): : 344 - 350
  • [24] Expression of plasminogen activator inhibitor-1 and tissue-type plasminogen activator in liver of rats with nonalcoholic fatty liver disease
    Fan, JG
    GASTROENTEROLOGY, 2004, 126 (04) : A690 - A690
  • [25] Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
    Zaid Al-Hamodi
    Ikram S Ismail
    Riyadh Saif-Ali
    Khaled A Ahmed
    Sekaran Muniandy
    Cardiovascular Diabetology, 10
  • [26] Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
    Al-Hamodi, Zaid
    Ismail, Ikram S.
    Saif-Ali, Riyadh
    Ahmed, Khaled A.
    Muniandy, Sekaran
    CARDIOVASCULAR DIABETOLOGY, 2011, 10
  • [27] Impact of Ethnicity on the Association of Plasminogen Activator Inhibitor-1 and Tissue Plasminogen Activator Polymorphisms with Type 2 Diabetes Mellitus
    Al-Hamodi, Z.
    Saif-Ali, R.
    Ismail, I. S.
    Poh, R.
    Ahmed, R. H.
    Muniandy, S.
    PUBLIC HEALTH GENOMICS, 2015, 18 : 30 - 30
  • [28] The plasminogen activator inhibitor-1 and the angiotensin II Type 1 receptor genes and their association with diabetic nephropathy among smokers
    Möllsten, A
    Kockum, I
    Rudberg, S
    Svensson, M
    Ugarph, A
    Brismar, K
    Eriksson, JW
    Dahlquist, G
    DIABETOLOGIA, 2003, 46 : A335 - A335
  • [29] Plasminogen activator inhibitor-1 gene polymorphism as a risk factor for vascular complications in type 2 diabetes mellitus
    Khalaf, Fatma A.
    Ibrahim, Hatem R.
    Bedair, Hanan M.
    Allam, Maha M.
    Elshormilisy, Amr A.
    Ali, Samia T.
    Gaber, Waseem M.
    EGYPTIAN JOURNAL OF MEDICAL HUMAN GENETICS, 2019, 20 (01)
  • [30] Plasminogen activator inhibitor-1 gene polymorphism as a risk factor for vascular complications in type 2 diabetes mellitus
    Fatma A. Khalaf
    Hatem R. Ibrahim
    Hanan M. Bedair
    Maha M. Allam
    Amr A. Elshormilisy
    Samia T. Ali
    Waseem M. Gaber
    Egyptian Journal of Medical Human Genetics, 20
12345